CANADIAN HEALTHCARE COMMERCIALIZATION
Bringing Global Healthcare Innovation to Canada.
Curegen partners with international healthcare companies to navigate market entry, commercialization and growth in Canada — across consumer health, natural health products, OTC and pharmaceutical products.
WHAT WE DO
From Product to Canadian Market
Curegen works with international healthcare manufacturers to transform promising products into commercially viable Canadian opportunities.
01
Market Entry
Evaluating the Canadian market, competitive landscape, positioning and commercial opportunity.
02
Regulatory Coordination
Working with experienced Canadian regulatory partners to determine the appropriate pathway and support registration.
03
Commercialization
Developing launch strategy, pricing, positioning, channel strategy and market-development plans.
04
Market Access & Sales
Building relationships with retailers, distributors, wholesalers, purchasing groups and Canadian healthcare channels.
FOCUS AREAS
A broader view of health.
Curegen is building a focused portfolio across categories where consumer relevance, scientific credibility and commercial potential meet.
01
Consumer Health & Wellness
02
Natural Health Products
03
OTC & OTC-Adjacent Healthcare
04
Specialty Healthcare Products
05
Pharmaceuticals & Generics
WHY CANADA / WHY CUREGEN
A Local Partner for a Complex Market
Entering Canada requires more than regulatory approval. Products need the right positioning, pricing, distribution, retailer access, commercial strategy and local execution.
Canadian market knowledge
International sourcing network
Healthcare commercialization focus
Flexible partnership structures
Specialized regulatory and operational partners
COMMERCIALIZATION MODEL
A clear pathway from discovery to growth.
01 Discover
Identify differentiated healthcare products and technologies.
02 Evaluate
Assess market opportunity, competition, regulatory pathway and viability.
03 Register
Coordinate the appropriate Canadian strategy with specialized partners.
04 Launch
Develop positioning, pricing, channel strategy and market-entry execution.
05 Scale
Expand distribution, retail presence, partnerships and market penetration.
INTERNATIONAL PARTNERSHIPS
Global Innovation. Canadian Execution.
Curegen works with manufacturers and healthcare innovators internationally to introduce differentiated products to Canada. We consider differentiation, Canadian market need, regulatory feasibility and commercial potential.
Built for product companies with a Canadian ambition.
Our role is to assemble the right commercial pathway and specialist relationships for each opportunity.
PARTNERSHIPS
Looking to Enter the Canadian Market?
We are actively evaluating differentiated healthcare products for Canadian commercialization. If your company has an innovative consumer-health, natural-health, OTC or pharmaceutical product with international potential, we would like to hear from you.
CONTACT
Start a conversation.
International manufacturers and healthcare companies interested in Canadian commercialization opportunities are invited to contact our team.
OUR INTERNATIONAL NETWORK
Part of TransArabia Drug Store
Curegen is part of TransArabia Drug Store (TADS), a specialty pharmaceutical distribution and marketing company based in Dubai. This relationship connects Curegen’s Canadian commercialization focus with an established international healthcare business network.
Together, Curegen and TADS bring complementary market knowledge and partnership capabilities across the Canadian and Middle Eastern healthcare landscapes.
ABOUT CUREGEN
Focused on the Canadian opportunity.
Curegen Pharma Inc. is a Canadian healthcare commercialization company focused on identifying, introducing and growing differentiated healthcare products in Canada.
Curegen combines international business-development capabilities with Canadian market knowledge and a network of regulatory, distribution and commercialization partners. The company is part of a broader international healthcare business network with experience working across multiple markets.